Based on the results of Kaplan-Meier, the overall survival of colon cancer patients with OLR1 low expression was dramatically longer than that in patients with high expression (Fig. 1I), which was consistent with the biological prediction. The gene discussed is OLR1; the disease is colonic neoplasm.